14906-62-8

Usage

Uses

Used in Pharmaceutical Industry:
3-Ethylpyridine 1-oxide is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs, contributing to its medicinal properties and potential therapeutic applications.
Used in Perfumery:
In the fragrance industry, 3-Ethylpyridine 1-oxide is used as a scent component. Its distinct aromatic profile can be incorporated into perfumes and other scented products to create complex and appealing olfactory experiences.
Used in Chemical Reactions:
3-Ethylpyridine 1-oxide serves as a reactant in various chemical processes. Its reactivity and stability make it a valuable compound for use in the synthesis of other organic compounds, contributing to the advancement of chemical research and development.
Safety Note:
It is important to handle 3-Ethylpyridine 1-oxide with care, as exposure to 3-Ethylpyridine 1-oxide may be harmful if ingested or absorbed through the skin. Proper safety measures should be taken to minimize the risk of adverse health effects.

InChI:InChI=1/C7H9NO/c1-2-7-4-3-5-8(9)6-7/h3-6H,2H2,1H3

Upstream product

• 536-78-7 3-ethylpyridine 

Downstream Products

• 14188-94-4 3-acetylpyridine N-oxide 
• 35363-12-3 3-ethyl-4-nitropyridine N-oxide 
• 59525-26-7 6-ethyl-1-phenyl-1,8a-dihydro-[1,2,4]oxadiazolo[2,3-a]pyridin-2-one 
• 59525-25-6 8-ethyl-1-phenyl-1,8a-dihydro-[1,2,4]oxadiazolo[2,3-a]pyridin-2-one 
• 14178-13-3 5-ethyl-pyridine-2-carbonitrile 
• 58515-54-1 3-ethyl-2-pyridinecarbonitrile 
• 13341-18-9 3-ethylpyridine-4-carbonitrile 
• 124300-40-9 5-ethyl-2-phenylethynyl-pyridine 
• 124300-39-6 3-Ethyl-2-phenylethynyl-pyridine 
• 37978-19-1 4-acetyl-3-ethylpyridine 
• 42753-67-3 2-amino-3-ethylpyridine 
• 19842-07-0 5-ethylpyridin-2-yl amine 
• 102235-18-7 3-ethyl-4-pyridinemethanol 
• 1192021-71-8 N-[4-chloro-2-hydroxy-5-(trifluoromethyl)phenyl]-3-ethyl isonicotinamide 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS AND USES THEREOF

Provided herein are novel heterocyclic compounds, for example, compounds having Formula I, I-P, II, lI-P, or III. Also provided herein are pharmaceutical compositions comprising the compounds and methods of using the same, for example, in inhibiting aldehyde dehydrogenases and/or for treating various cancers, cancer metastasis, type 2 diabetes, pulmonary arterial hypertension (PAH) or neointimal hyperplasia (NIH).

HARMFUL ARTHROPOD CONTROL COMPOSITION, AND FUSED HETEROCYCLIC COMPOUND

Disclosed is a harmful arthropod control composition comprising, as an active ingredient, a fused heterocyclic compound represented by formula (1) [wherein A1 and A2 independently represent a nitrogen atom or the like; R1 and R4 independently represent a halogen atom or the like; R2 and R3 independently represent a halogen atom or the like; R5 and R6 independently represent a linear C1-C6 hydrocarbon group which may be substituted, or the like (provided that both R5 and R6 cannot represent a hydrogen atom simultaneously); and n represents 0 or 1]. The harmful arthropod control composition has an excellent efficacy to control harmful arthropods.

HARMFUL ARTHROPOD CONTROL COMPOSITION, AND FUSED HETEROCYCLIC COMPOUND

Disclosed is a harmful arthropod control composition comprising, as an active ingredient, a fused heterocyclic compound represented by formula (1) [wherein A1 and A2 independently represent a nitrogen atom or the like; R1 and R4 independently represent a halogen atom or the like; R2 and R3 independently represent a halogen atom or the like; R5 and R6 independently represent a linear C1-C6 hydrocarbon group which may be substituted, or the like (provided that both R5 and R6 cannot represent a hydrogen atom simultaneously); and n represents 0 or 1]. The harmful arthropod control composition has an excellent efficacy to control harmful arthropods.

COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS

The present invention provides: an arthropod pests control composition comprising, as active ingredients, a condensed heterocyclic compound and a neonicotinoid compound; a method for controlling arthropod pests which comprises applying effective amounts of a condensed heterocyclic compound and a neonicotinoid compound to the arthropod pests or a locus where the arthropod pests inhabit; and so on.

COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS

The present invention provides: an arthropod pests control composition comprising, as active ingredients, a condensed heterocyclic compound and pyriproxyfen; a method for controlling arthropod pests which comprises applying effective amounts of a condensed heterocyclic compound and pyriproxyfen to the arthropod pests or a locus where the arthropod pests inhabit; and so on.

COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS

The present invention provides: an arthropod pests control composition comprising, as active ingredients, a condensed heterocyclic compound and a pyrethroid compound; a method for controlling arthropod pests which comprises applying effective amounts of a condensed heterocyclic compound and a pyrethroid compound to the arthropod pests or a locus where the arthropod pests inhabit; and so on.

COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS

The present invention provides: an arthropod pests control composition comprising, as active ingredients, a condensed heterocyclic compound and pyridalyl; a method for controlling arthropod pests which comprises applying effective amounts of a condensed heterocyclic compound and pyridalyl to the arthropod pests or a locus where the arthropod pests inhabit; and so on.

COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS

The present invention provides: an arthropod pests control composition comprising, as active ingredients, a condensed heterocyclic compound and a diamide compound; a method for controlling arthropod pests which comprises applying effective amounts of a condensed heterocyclic compound and a diamide compound to the arthropod pests or a locus where the arthropod pests inhabit; and so on.

A comparison of methods for N-oxidation of some 3-substituted pyridines

The results from the N-oxidation of four 3-substituted pyridines using five different reagents are reported. The best yields are obtained with m-chloroperoxybenzoic acid.

Biotransformation of phenyl- and pyridylalkane derivatives in rat liver 9,000xg supernatant (S-9)

When phenylpropanes were incubated with phenobarbital-pretreated rat liver 9,000xg supernatant (S-9), oxidative hydroxylation occurred to give phenylpropanol (racemic), (1R, 2S)- and (1R, 2R)-phenylpropanediols, (2S)-hydroxyphenylpropanone. Incubation of pyridylethane and propane with S-9 afforded α-pyridylethanol and propanol, but those were optically inactive. During the incubation of 1-phenylpropanone, an asymmetric redox reaction simultaneously occurred to give (2S)-phenylpropanol, (1R, 2S)- or (1R, 2R)-phenylpropanediols and (2R)-hydroxyphenylpropanone. Acetylpyridines were enantioselectively reduced to afford α-pyridylethanols in high optical yields (94-98%ee). The oxidation of pyridylalkane was significantly inhibited by cytochrome P-450 inhibitor (SKF-525A), but reduction of acetylpyridines was not inhibited. Thus, cytochrome P-450 was found to be responsible for the oxidation of pyridylalkane, but not for the reduction of the ketone.